Skip to main content

Peer Review reports

From: Integrating traditional biomarkers and emerging predictors to assess neoadjuvant chemotherapy efficacy in breast cancer: a multifactorial analysis of Ki-67, CDK4, EGFR, TILs and ctDNA

Original Submission
7 Aug 2024 Submitted Original manuscript
10 Aug 2024 Reviewed Reviewer Report
15 Sep 2024 Reviewed Reviewer Report
18 Sep 2024 Reviewed Reviewer Report - Yuquan Chen
18 Sep 2024 Reviewed Reviewer Report - Víctor Manuel Vargas-Hernández
19 Sep 2024 Reviewed Reviewer Report
20 Sep 2024 Reviewed Reviewer Report
20 Sep 2024 Reviewed Reviewer Report - Ban Hadi Hameed
20 Sep 2024 Reviewed Reviewer Report - Michael Odida
21 Sep 2024 Reviewed Reviewer Report - Phuc Nhon Nguyen
21 Sep 2024 Reviewed Reviewer Report - Burak Sezgin
22 Sep 2024 Reviewed Reviewer Report
23 Sep 2024 Reviewed Reviewer Report
24 Sep 2024 Reviewed Reviewer Report
24 Sep 2024 Reviewed Reviewer Report
19 Nov 2024 Author responded Author comments - Shulan Sun
23 Nov 2024 Reviewed Reviewer Report
24 Nov 2024 Reviewed Reviewer Report
24 Nov 2024 Reviewed Reviewer Report - Ban Hadi Hameed
24 Nov 2024 Reviewed Reviewer Report - Yuquan Chen
24 Nov 2024 Reviewed Reviewer Report
24 Nov 2024 Reviewed Reviewer Report - Phuc Nhon Nguyen
26 Nov 2024 Reviewed Reviewer Report
26 Nov 2024 Reviewed Reviewer Report
26 Nov 2024 Reviewed Reviewer Report - Michael Odida
Resubmission - Version 2
19 Nov 2024 Submitted Manuscript version 2
Publishing
28 Nov 2024 Editorially accepted
30 Dec 2024 Article published 10.1186/s12905-024-03486-1

You can find further information about peer review here.

Back to article page